SUNSHINE BIOPHARMA INC (SBFM)

Company Profile

Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. The company is headquartered in Pointe-Claire, Quebec and currently employs 46 full-time employees. The company went IPO on 2008-08-15. The firm offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The firm has 27 additional generic prescription drugs. In addition, the Company is engaged in the development of various proprietary drugs, including Adva-27a, K1.1 mRNA and SBFM-PL4. Adva-27a is a small chemotherapy molecule targeting pancreatic cancer. The K1.1 mRNA is developed for liver cancer. SBFM-PL4 is an anti-coronavirus compound. The firm operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The company also operates two wholly owned subsidiaries: NoraPharma Inc., which has a portfolio consisting of 50 generic prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells non-prescription over-the-counter (OTC) products.

Company Info

SUNSHINE BIOPHARMA INC

6500 Trans-Canada Highway, 4th Floor

Pointe-Claire QUEBEC

P: 15144266161

Employees: 46

Website: https://www.sunshinebiopharma.com/